Published in Clin Radiol on March 01, 1996
Metastatic tumours of bones of the hand and foot. A comparative review and report of 43 additional cases. Skeletal Radiol (1987) 2.14
Renal failure in multiple myeloma: incidence, correlations, and prognostic significance. Leuk Lymphoma (2007) 1.96
Reduction of osteonecrosis of the jaw (ONJ) after implementation of preventive measures in patients with multiple myeloma treated with zoledronic acid. Ann Oncol (2008) 1.74
Features of unusual metastases from prostate cancer. Br J Radiol (1999) 1.62
Orchidectomy alone in testicular stage I non-seminomatous germ-cell tumours. Lancet (1982) 1.58
Dynamic contrast enhanced MRI of prostate cancer: correlation with morphology and tumour stage, histological grade and PSA. Clin Radiol (2000) 1.54
A randomised phase III trial of adjuvant radio-chemotherapy comparing Irinotecan, 5FU and Leucovorin to 5FU and Leucovorin in patients with rectal cancer: a Hellenic Cooperative Oncology Group Study. Eur J Cancer (2008) 1.47
Evaluating the effect of rectal distension and rectal movement on prostate gland position using cine MRI. Int J Radiat Oncol Biol Phys (1999) 1.39
Pulmonary toxicity from novel antineoplastic agents. Ann Oncol (2005) 1.39
Probing tumor microvascularity by measurement, analysis and display of contrast agent uptake kinetics. J Magn Reson Imaging (1997) 1.39
Dynamic contrast-enhanced MRI studies in oncology with an emphasis on quantification, validation and human studies. Clin Radiol (2001) 1.33
Colorectal hepatic metastases: quantitative measurements using single-shot echo-planar diffusion-weighted MR imaging. Eur Radiol (2006) 1.32
Primary breast cancer: mammographic changes after neoadjuvant chemotherapy, with pathologic correlation. Radiology (1996) 1.29
The role of computed tomography in the management of testicular teratoma. Clin Radiol (1979) 1.28
Irinotecan or oxaliplatin combined with leucovorin and 5-fluorouracil as first-line treatment in advanced colorectal cancer: a multicenter, randomized, phase II study. Ann Oncol (2005) 1.28
Commentary. Are current tumour response criteria relevant for the 21st century? Br J Radiol (2000) 1.17
Phase II study of temozolomide in heavily pretreated cancer patients with brain metastases. Ann Oncol (2001) 1.16
Detection of colorectal hepatic metastases using MnDPDP MR imaging and diffusion-weighted imaging (DWI) alone and in combination. Eur Radiol (2008) 1.16
Comparison of ultrasound and computer-assisted tomography in pancreatic diagnosis. Br J Radiol (1977) 1.16
Benign thymic enlargement in adults after chemotherapy: CT demonstration. Radiology (1987) 1.14
Normal pelvic lymph nodes: evaluation with CT after bipedal lymphangiography. Radiology (1995) 1.13
Endocardial metastases as the only site of relapse in a patient with bladder carcinoma: a case report and review of the literature. Int J Cardiol (2008) 1.11
Effects of androgen deprivation on prostatic morphology and vascular permeability evaluated with mr imaging. Radiology (2001) 1.10
Thalidomide in cancer medicine. Ann Oncol (2004) 1.10
Squamous cell carcinoma of the uterine cervix. Patterns of thoracic metastases. Invest Radiol (1995) 1.10
Prevention of chemotherapy-induced alopecia using an effective scalp cooling system. Eur J Cancer (2000) 1.08
Focal sparing in fatty infiltration of the liver. Br J Radiol (1986) 1.07
In vivo monitoring of tumor angiogenesis with MR imaging. Acad Radiol (2000) 1.06
Clinical outcome and restenosis following percutaneous transluminal angioplasty for ischaemic rest pain or ulceration. Br J Surg (1995) 1.06
Unusual thoracoabdominal sites of metastases in testicular tumors. AJR Am J Roentgenol (1985) 1.03
Bleomycin-related lung damage: CT evidence. Radiology (1985) 1.00
Magnetic resonance imaging in suspected metastatic spinal cord compression. Clin Radiol (1989) 1.00
CT of primary germ-cell tumors of the mediastinum. AJR Am J Roentgenol (1984) 0.99
Comparison of computed tomography and conventional radiology in the assessment of treatment response of lytic bony metastases in patients with carcinoma of the breast. Clin Radiol (1987) 0.98
The outcome of advanced or recurrent non-squamous carcinoma of the uterine cervix after platinum-based combination chemotherapy. Gynecol Oncol (2005) 0.94
Ovarian metastases from primary gastrointestinal malignancies: the Royal Marsden Hospital experience and implications for adjuvant treatment. Br J Cancer (1995) 0.94
VEGF directly suppresses activation of T cells from ascites secondary to ovarian cancer via VEGF receptor type 2. Br J Cancer (2012) 0.93
T1-weighted magnetic resonance imaging in breast cancer vertebral metastases: changes on treatment and correlation with response to therapy. Clin Radiol (1998) 0.93
Brain metastases as isolated site of relapse in patients with epithelial ovarian cancer previously treated with platinum and paclitaxel-based chemotherapy. Int J Gynecol Cancer (2006) 0.93
Paclitaxel and gemcitabine versus carboplatin and gemcitabine in patients with advanced non-small-cell lung cancer. A phase III study of the Hellenic Cooperative Oncology Group. Ann Oncol (2007) 0.92
Symptomatic brachial plexopathy following treatment for breast cancer: utility of MR imaging with surface-coil techniques. Radiology (2000) 0.92
Docetaxel and cisplatin combination chemotherapy in advanced carcinoma of the urothelium: a multicenter phase II study of the Hellenic Cooperative Oncology Group. Ann Oncol (1999) 0.90
Intrathoracic manifestations of metastatic testicular seminoma: a comparison of chest radiographic and CT findings. AJR Am J Roentgenol (1987) 0.90
The role of intravenous contrast enhancement in magnetic resonance imaging of prostatic carcinoma. Clin Radiol (1995) 0.90
Cross-sectional imaging of nodal metastases in the abdomen and pelvis. Abdom Imaging (2007) 0.90
Distribution of mesorectal lymph nodes in rectal cancer: in vivo MR imaging compared with histopathological examination. Initial observations. Eur Radiol (2005) 0.89
Tumour localisation with a radioactively labelled reshaped human monoclonal antibody. Br J Cancer (1991) 0.89
MRIW: parametric analysis software for contrast-enhanced dynamic MR imaging in cancer. Radiographics (1998) 0.89
Elective delayed excision of bulky para-aortic lymph node metastases in advanced non-seminoma germ cell tumours of testis. Br J Urol (1981) 0.89
The use of computed tomography in recurrent rectal tumors. Radiology (1980) 0.88
Epithelial ovarian carcinoma in younger vs older women: is age an independent prognostic factor? The Hellenic Oncology Cooperative Group experience. Int J Gynecol Cancer (2007) 0.88
CT of calcified liver metastases in colorectal carcinoma. Clin Radiol (1998) 0.88
The impact of age in the outcome of patients with advanced or recurrent cervical cancer after platinum-based chemotherapy. Gynecol Oncol (2006) 0.87
The role of computed tomography-guided needle biopsy in an oncology service. Clin Radiol (1983) 0.86
Nodal staging in rectal cancer. Abdom Imaging (2007) 0.85
What is the prevalence of symptomatic or asymptomatic femoral head osteonecrosis in patients previously treated with chemoradiation? A magnetic resonance study of anal cancer patients. Clin Oncol (R Coll Radiol) (2001) 0.85
Evaluation of computed tomography in the management of testicular teratoma. Br J Urol (1981) 0.85
Normal lymph node size in the mediastinum: a retrospective study in two patient groups. Clin Radiol (1989) 0.84
Ewing sarcoma: MR imaging of chemotherapy-induced changes with histologic correlation. Radiology (1992) 0.84
The role of computed tomography in the staging of bladder cancer. Clin Radiol (1979) 0.84
Pelvic phased-array MR imaging of anal carcinoma before and after chemoradiation. Br J Radiol (2008) 0.84
Significance of thoracic disc herniation demonstrated by MR imaging. J Comput Assist Tomogr (1989) 0.84
The periosteal sunburst reaction to bone metastases. A literature review and report of 20 additional cases. Skeletal Radiol (1987) 0.83
Minichromosome maintenance proteins 2 and 5 in non-benign epithelial ovarian tumours: relationship with cell cycle regulators and prognostic implications. Br J Cancer (2007) 0.83
Thymidine phosphorylase to dihydropyrimidine dehydrogenase ratio as a predictive factor of response to preoperative chemoradiation with capecitabine in patients with advanced rectal cancer. J Surg Oncol (2010) 0.83
Blinded comparison of faecal loading on plain radiography versus radio-opaque marker transit studies in the assessment of constipation. Clin Radiol (2008) 0.82
Combination of docetaxel, estramustine phosphate, and zoledronic acid in androgen-independent metastatic prostate cancer: efficacy, safety, and clinical benefit assessment. Urology (2005) 0.82
Comparative efficacy of and sequence choice for two oral contrast agents used during MR imaging. AJR Am J Roentgenol (1999) 0.82
Computed tomography screening for lung cancer: back to basics. Clin Radiol (2001) 0.82
Mediastinal lymph node metastases from gastrointestinal carcinoma. Cancer (1987) 0.81
Evaluation by magnetic resonance imaging of the inferior vena cava in patients with non-seminomatous germ cell tumours of the testis metastatic to the retroperitoneum. Br J Urol (1997) 0.81
Computed tomography of abdominal carcinoid tumors. AJR Am J Roentgenol (1984) 0.81
The role of computed tomography in the management of soft tissue sarcomas. Br J Radiol (1982) 0.81
Pneumomediastinum complicating bleomycin related lung damage. Br J Radiol (1998) 0.81
Quantitative assessment of lung damage due to bleomycin using computed tomography. Br J Radiol (1987) 0.81
CT estimations of mean attenuation values and volume in testicular tumors: a comparison with surgical and histologic findings. Radiology (1982) 0.81
Correlation of CT with histopathological findings in patients with gastric and gastro-oesophageal carcinomas following neoadjuvant chemotherapy. Clin Radiol (1998) 0.81
Multiple myeloma: appearance at MR imaging. Radiology (1992) 0.81
Role of the CT scanner in the management of cancer. Br Med J (Clin Res Ed) (1985) 0.80
Hodgkin disease: CT of the thymus. Radiology (1988) 0.80
Immunohistochemical and immunocytochemical study of bladder carcinomas using the epithelium-specific, tumour-associated monoclonal antibodies HMFG1 and AUA1. Br J Cancer Suppl (1990) 0.80
Magnetic resonance imaging in recurrent carcinoma of the cervix. Br J Radiol (1989) 0.80
CT scanning in carcinoma of the rectum: a review. J R Soc Med (1987) 0.80
DNA ploidy as a prognostic factor in muscle invasive transitional cell carcinoma of the bladder. Urol Res (2004) 0.80
Radiation induced liver injury detected by particulate reticuloendothelial contrast agent. Br J Radiol (1998) 0.80
Computed tomography in testicular disease: a review. J R Soc Med (1981) 0.80
Tumour staging using magnetic resonance imaging in clinically localised prostate cancer: relationship to biochemical outcome after neo-adjuvant androgen deprivation and radical radiotherapy. Clin Oncol (R Coll Radiol) (2005) 0.80
High-dose melphalan and autologous stem cell transplantation as consolidation treatment in patients with chemosensitive ovarian cancer: results of a single-institution randomized trial. Bone Marrow Transplant (2007) 0.80
Epithelial ovarian cancer in Greece: a retrospective study of 1,791 patients by the Hellenic Cooperative Oncology Group (HeCOG). Anticancer Res (2009) 0.80
Immunolocalisation of testicular tumours using radiolabelled monoclonal antibody to placental alkaline phosphatase. J Nucl Med Allied Sci (1991) 0.80
CT demonstration of retinal detachment secondary to choroidal metastatic disease. Br J Radiol (1985) 0.80
Intramedullary spinal cord and leptomeningeal metastases in a patient with carcinoma of the uterine cervix. Gynecol Oncol (2006) 0.79
Thymic rebound in an adult following chemotherapy for testicular cancer. Eur J Surg Oncol (1986) 0.79
Radiology of soft tissue sarcoma: discussion paper. J R Soc Med (1982) 0.79
Uptake and distribution of specific and control monoclonal antibodies in subcutaneous xenografts following intratumor injection. Cancer Res (1991) 0.79
Adjuvant chemotherapy with paclitaxel and carboplatin in non-endometrioid carcinoma of the uterus. Eur J Gynaecol Oncol (2005) 0.79
Assessment of response following treatment for malignant disease. Br J Radiol (1997) 0.78
Multicenter phase-II trial of irinotecan plus oxaliplatin [IROX regimen] in patients with poor-prognosis cancer of unknown primary: a hellenic cooperative oncology group study. Cancer Chemother Pharmacol (2007) 0.78
[Comparative evaluation of computerized tomography/magnetic resonance (1.5 T) in the detection of brain metastasis]. Radiol Med (1991) 0.78